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Abstract
Background: Chronic fatigue syndrome (CFS) is a disease which defined as medically unexplained,
disabling fatigue of 6 months or more duration and often accompanied by several of a long list of
physical complaints. We aimed to investigate abnormalities of hypothalamic-pituitary-gonadal
(HPG) axis hormones and cortisol concentrations in premenopausal women with CFS and find out
effects of depression rate on these hormones.
Methods: We examined follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol,
progesterone and cortisol concentrations in 43 premenopausal women (mean age: 32.86 ± 7.11)
with CFS and compared matched 35 healthy controls (mean age: 31.14 ± 6.19). Patients were
divided according to menstrual cycle phases (follicular and luteal) and compared with matched
phase controls. Depression rate was assessed by Beck Depression Inventory (BDI), and patients
with high BDI scores were compared to patients with low BDI scores.
Results: There were no significant differences in FSH, LH, estradiol and progesterone levels in
both of menstrual phases of patients versus controls. Cortisol levels were significantly lower in
patients compared to controls. There were no significant differences in all hormone levels in
patients with high depression scores versus patients with low depression scores.
Conclusion: In spite of high depression rate, low cortisol concentration and normal HPG axis
hormones of both menstrual phases are detected in premenopausal women with CFS. There is no
differentiation between patients with high and low depression rate in all hormone levels.
Depression condition of CFS may be different from classical depression and evaluation of HPG and
HPA axis should be performed for understanding of pathophysiology of CFS and planning of
treatment.
Background
Chronic fatigue syndrome (CFS) is a clinical presentation
that primarily affects women and characterized by severe
disabling fatigue, and other symptoms; including muscu-
loskeletal pain, sleep disturbance, impaired concentra-
tion, and headaches, in the absence of organic illness or
severe psychiatric disorder that would explain the fatigue.
For diagnosis of CFS operational criteria have been
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developed by Centers for Disease Control (CDC) [1].
Although the cause CFS is poorly understood, there are
some causative theories for underlying conditions.
Hypotheses about its etiology have included viral infec-
tions, immune dysregulation and abnormal endocrine
function among others [2].
It has been reported that onset of CFS mostly following a
significant stressor, most frequently a viral infection, and
the course of the syndrome remits and relapses with
occurrence of physical and psychological stressors [3].
Stress is known to interfere with the menstrual cycle and
may lead to chronic anovulation and amenorrhea [4].
This generally thought to be caused by a decrease in the
activity of hypothalamic gonadotropin releasing hor-
mone (GnRH) pulse generator with subsequent inhibi-
tion of the pituitary-gonadal axis [5,6]. Stress-induced
activation of hypothalamic-pituitary-adrenal (HPA) hor-
monal axis plays an important role in suppressing the
HPG axis [7]. Infusion of corticotropin releasing hormone
(CRH) into the cerebral ventricles leads to inhibition of
LH secretion in primates [8]. CRH antagonism has also
been shown to prevent the inhibitory effect of stress on
the HPG axis in the rodent and in the monkey [9].
Women with hypothalamic amenorrhea have higher
basal cortisol levels and blunted cortisol response to exog-
enous administration of CRH, suggesting that the increase
in cortisol secretion may reflect increased endogenous
CRH activity [10].
Pertuberations of HPA axis function have been described
in CFS [11,12]. Studies of the HPA axis in CFS show a
mild hypocortisolism of central origin, in contrast to the
hypercortisolism of major depression [13,14]. There are
similarites between onset, course, and clinical syndromes
of CFS and glucocorticoid defficiency states. Clinical syn-
dromes of CFS and Addison's disease share many com-
mon features: one of the principal clinical features of
Addison's is fatigue, the core feature of CFS. The other
common symptoms of CFS include arthralgia, myalgia,
adenopathy, exacerbation of allergic responses, intermit-
tent fever, postexertional fatigue, and depressed mood.
These symptoms can also be experienced by those with-
drawing from hypercortisolaemic states [15].
CFS occurs more commonly in women [16]. It was sug-
gested that alterations in reproductive hormone levels
might be involved in the pathoetiology of CFS [17]. There
has been reported that this condition may be due to estro-
gen deficiency and reflect underactivity of the HPG hor-
monal axis [18]. The GnRH secretion from hypothalamus
drives secretion of LH and FSH from pituitary gonado-
tropes [19]. FSH and LH govern the cyclical secretion of
estradiol and progesterone over the course of menstrual
cycle. The pulsatile pattern of GnRH secretion is critical
for the control of serum LH, FSH, and ovulation.
Interaction between HPA and HPG axes in stress-induced
amenorrhea suggests that there may be perturbation of
these axes in CFS. One important confound is co-morbid
depressive illness, present in approximately 50% of CFS
patients [20]. Relation between depressive mood and
these axes has been more investigated yet. This relation-
ship may contribute to clarification of pathoetiology of
CFS and to describe treatment strategy of this complex
syndrome.
In this study, we aimed to investigate main hormones of
HPG and HPA axes; FSH, LH, estradiol, progesterone and
cortisol levels in premenopausal women with CFS. Fur-
thermore to find out relationship between these hor-
mones and depressive mood with comparing patients
with high and low depression scores.
Methods
Subjects
A total of 43 premenopausal women diagnosed as CFS,
according to the international CFS definition criteria [1],
were recruited from outpatient clinic of Physical Medicine
and Rehabilitation Department of Dicle University (Diya-
rbakýr, Turkey) for this study. Fatigue assessment was
done according to CDC criteria [1]. Fatigue characteristics
are persistent or recurrent lasting at least 6 months; recent
and/or well defined onset; not secondary to excessive
physical activity, or any organic or psychiatric disorders;
not resolved by rest; and inducing important reduction of
previous levels of physical and mental activities. Thirty
five age matched demographically similar healthy pre-
monopausal women were also selected as controls. Ethic
committee of Dicle University hospital approved the
study, and all subjects voluntarily agreed to participate.
All patients underwent medical screening that included
physical examination and relevant investigation, with a
minimum of urine analysis, full blood count, measure-
ment of urea, electrolytes, and erythrocyte sedimentation
rate, and test for thyroid and liver function. All patients
and controls were evaluated by structered psychiatric
interview to exclude any additional psychiatric disorder
prior to inclusion in the study. Depression rate was
assessed by Beck Depression Inventory (BDI) in all
patients and controls. Patients with CFS were divided to
two groups according to the BDI higher and lower than 17
scores. All prescription medications, included psychoac-
tive and non-prescription medications, vitamins, and
herbal remedies were tapered and then stopped at least 2
weeks prior to study [17,21]. All subjects and controls had
no frank hypocortisolism on endocrine assessment. No
patients and controls had received any oral or intraarticu-
lar corticosteroid therapy during the three monthsBMC Musculoskeletal Disorders 2004, 5:47 http://www.biomedcentral.com/1471-2474/5/47
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preceding the study, or had received exogenous estrogens,
progesterone, or any other drugs affecting sex or cortisol
hormones metabolism. The other exclusion critetria [1]
were: active, unresolved, or suspected disease likely to
cause fatigue; alcohol or other substance abuse within 2
years prior to onset of the chronic fatigue and any time
afterward; and a body mass index ≥45. All subjects and
controls were undergoing normal menstrual cycles and
were not taking contraceptive pill. Subjects and controls
were all studied during the follicular (n: 28 with CFS and
n: 23 controls) and luteal (n: 15 with CFS and n: 12 con-
trols) phases of menstrual cycle.
Procedures and Hormone Assays
Blood samples were collected in the early morning (8.30–
10.30 AM) after an all night fast and plasma was separated
immediately by centrifugation; then sera obtained were
stored at -20°C until hormonal assaying. All hormone
values assayed by "Electro Chemil Luminescence Immu-
nassay (ECLIA)" (Roche, 1010/1020 Elecsys Systems
Immunoassay) method. Serum concentrations of follicle
stimulating hormone (FSH, normal values 3.3 to 11.3
mIU/mL for follicular phase and 1.8 to 8.2 mIU/mL for
lueal phase), luteinizing hormone (LH, normal values 2.4
to 12.6 mIU/mL for follicular phase and 1.0 to 11.4 mIU/
mL for luteal phase), estradiol (E2, normal values 24.5 to
195 pg/mL for follicular phase and 40 to 261 pg/mL for
luteal phase), progesterone (normal values 0–1.6 ng/mL
for follicular phase and 1.1 to 21 ng/mL for luteal phase),
and cortisol (normal values 6.2 to 19.4 µgr/dl) were eval-
uated in all patients and controls in both of menstrual
periods.
Statistical analysis
were done by SPSS 8.0 PC program. Results were
expressed as means ± SD (standard deviation). Statistical
significances were tested using the independent student's
t test for women with CFS and control group compari-
sons. Mann Whitney U test was used for comparison of
hormonal data of women in both phases of menstrual
cycle, and patients with high and low BDI scores groups
comparison. The level of statistical significance was set at
a two-tailed p-value of 0.05.
Results
All patients with CFS and healthy controls were reproduc-
tive premenopoausal women; and mean ages were 32.76
± 7.07 and 31.14 ± 6.19 respectively for both groups. All
of the patients had debilitating clinically evaluated and
medically unexplained fatingue that does not resolve with
bed rest and severe enough to significantly reduce daily
activity for at least 6 months. The other clinical findings of
patients with CFS were summarized in Table 1.
There wasn't significant differentiation between ages and
BMI of groups (p > 0.05). There were no significant differ-
ences between the means of FSH, LH, progesterone and
estradiol in all CFS patients compared to all controls (p >
0.05). Mean concentrations of cortisol were significantly
lower in all CFS patients than all controls (p < 0.001)
(Table 2).
There were no significant differences between the levels of
FSH, LH, progesterone and estradiol in CFS patients com-
pared to controls in follicular phase (p > 0.05). Mean con-
centrations of cortisol were significantly lower in CFS
patients than controls in follicular phase (p = 0.001)
(Table 3).
There were no significant differences between the levels of
FSH, LH, progesterone and estradiol in CFS patients com-
pared to controls in luteal phase (p > 0.05). Mean concen-
trations of cortisol were significantly lower in CFS patients
than controls in luteal phase (p < 0.05) (Table 4).
Table 1: Clinical findings of 43 patients with CFS
(N) (%)
Fatigue 43 100
Sore Throat 32 74.42
Arthralgıa 34 79.07
Myalgıa 39 90.7
Muscle Weaknes 71 6 . 2 7
Fever 24 55.8
Fharyngitis 32 74.42
Lenfadenopathy 31 72.1
Headache 23 53.5
Neuropsychologic findings 43 100
Sleep Disturbance 31 72.1
Table 2: HPG axis hormonal data and cortisol levels in all 
patients and controls
Patients (n = 43) Controls (n = 35) T p
Age 32.76 ± 7.07 31.14 ± 6.19 1.06 0.290
BMI 24.47 ± 4.37 24.63 ± 4.39 -0.147 0.883
BDI 21.83 ± 8.49 11.6 ± 3.45 6.68 0.000
FSH 6.57 ± 4.87 6.52 ± 7.45 0.034 0.973
LH 6.82 ± 5.72 7.09 ± 6.04 -0.202 0.841
Progesterone 2.23 ± 3.14 3.15 ± 4.21 -1.105 0.273
Estradiol 111.54 ± 176.83 89.08 ± 55.37 0.722 0.472
Cortisol 10.33 ± 4.55 15.11 ± 6.95 -3.64 0.000BMC Musculoskeletal Disorders 2004, 5:47 http://www.biomedcentral.com/1471-2474/5/47
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Fifty patients (69.76%) with CFS had ≥17 BDI scores.
Mean cortisol concentrations of patients with BDI scores
≥17 were higher than patients with BDI scores <17 but dif-
ferentiation wasn't significant. There were no significant
differences between these patients groups in HPG axis
hormone levels (Table 5).
Discussion
In this study, reproductive HPG axis hormone levels dem-
onstrated no significant differences in women with CFS
from controls during follicular and luteal phases. These
findings are in agreement with Korszun et al. [17] who
reported data from 9 premenopausal women with fibro-
myalgia and 8 with CFS. They showed no significant dif-
ferentiations of reproductive axis function in both of
patients groups in estrogen and progesterone levels, as
well as LH pulsatility during the follicular phase. How-
ever, Studd and Panay [18] reported data from 28 pre-
menopausal women with CFS 87 and of these, 25%
showed low plasma estradiol concentrations. The authors
reported that CFS may represent an hypoestrogenic state
and recommend the use of hormone replacement therapy
for women with CFS. In addition, they claim that 80% of
patients improved after treatment of estradiol patches and
cyclical progestagens.
Chronic fatigue syndrome is generally accepted stress
related disease and disfunction of HPA axis has been
reported in this syndrome [22]. In this study, cortisol lev-
els were lower in women with CFS compared to healthy
controls. Some sudies of HPA in CFS show a mild
hypocortisolism of central origin in contrast to hypercor-
tisolism of major depression [13,14]. In an early study of
the HPA axis in patients with CFS Demitract et al. [22]
reported low 24-hour urine free cortisol compared with
that of control subjects. Baseline evening plasma cortico-
tropin levels were elevated and cortisol levels were
depressed. Significantly lower baseline cortisol levels was
reported in an earlier study [23]. Despite these findings,
the majority of further studies have failed to replicate this.
Differentiations of studies methodology and sample char-
acteristics may explain the variety of results.
High circulating cortisol is well replicated finding in
major depression [24] and so presence of depression
makes the cortisol findings more difficult to interpret. Sig-
nificantly raised baseline cortisol levels in subjects with
CFS studied by Wood et al. [25] was explained by their
high BDI scores [20]. In this study, high BDI scores (≥17)
were detected in 69.76% of patients with CFS. There were
no significant high level of cortisol and HPG axis hor-
mone concentrations in patients with high BDI score
compared to patients with low BDI scores (<17). Scott
and Dinan [14] reported finding of low urine free cortisol
in patients with CFS compared with healthy controls. In
addition, there was no difference between depressed and
non depressed patients with CFS. These findings are in
agreement with our study. In another study [26] was
reported blunted corticotropin and cortisol in response to
administration of ovine CRH without differences in basal
levels.
Table 3: HPG axis hormonal data and cortisol levels in patients 
and controls in follicular phase
Patients (n = 28) Controls (n = 23) T P
Age 32.71 ± 7.43 30.74 ± 6.39 -1.17 0.240
BDI 22.85 ± 9.04 12.3 ± 3.26 -4.71 0.000
FSH 6.73 ± 5.32 7.91 ± 8.84 -0.142 0.88
LH 7.6 ± 6.37 8.34 ± 6.85 -0.58 0.55
Progesterone 1.96 ± 2.95 2.10 ± 3.56 -0.22 0.83
Estradiol 129.65 ± 217.05 89.66 ± 58.21 -0.21 0.83
Cortisol 10.12 ± 4.46 15.26 ± 7.17 -3.25 0.001
Table 4: HPG axis hormonal data and cortisol levels in patients 
and controls in luteal phase
Patients (n = 15) Controls (n = 12) T P
Age 32.86 ± 6.58 31.91 ± 5.99 -0.34 0.75
BDI 19.93 ± 7.26 10.25 ± 3.57 -3.30 0.000
FSH 6.26 ± 4.07 3.87 ± 1.99 -1.66 0.103
LH 5.36 ± 4.03 4.69 ± 3.05 -0.53 0.61
Progesterone 2.72 ± 3.5 5.19 ± 4.76 -1.415 0.167
Estradiol 77.73 ± 32.61 87.97 ± 51.94 -0.293 0.792
Cortisol 10.33 ± 4.3 14.81 ± 6.81 -2.001 0.047
Table 5: Cortisol levels in women with CFS according to BDI 
higher and lower than 17 scores
BDI ≥17 scores 
(n = 30)
BDI scores <17 
(n = 13)
TP
Age 33.76 ± 6.89 30.46 ± 7.20 -
1.52
0.13
0
BDI 25.93 ± 6.7 12.38 ± 2.29 -
5.17
0.00
0
FSH 6.62 ± 5.36 6.46 ± 3.72 -
0.21
2
0.84
LH 6.71 ± 6.25 7.08 ± 4.5 -
0.80
0.38
Progesterone 2.08 ± 2.92 2.56 ± 3.69 -
0.42
0.68
Estradiol 127.46 ± 206.32 74.79 ± 66.81 -
1.45
0.15
1
Cortisol 10.37 ± 4.65 9.78 ± 3.8 -
0.42
0.68BMC Musculoskeletal Disorders 2004, 5:47 http://www.biomedcentral.com/1471-2474/5/47
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Studies in primates have demonstrated that intracerebrov-
entricular infusion of CRH as well as proinflammatory
cytokines such as interleukin-1 can decrease LH secretion
[27,28]. Stress induced (hypothalamic) amenorrhea, as
well as exercise-induced amenorrhea and anorexia ner-
vosa, activate the HPA axis, increasing cortisol secretion
and decreasing corticotropin or cortisol response to exog-
enous CRH [29-31]. These HPA axis abnormalities are
similar to those seen in depression, suggesting that activa-
tion of the HPA axis may be linked to inhibition of the
HPG axis. Young et al. [32] found %30 lower plasma
estradiol level in women with depression than controls in
the follicular phase. The half-life LH was significantly
shorter in women with depression than controls during
both of the follicular and luteal phases. The other repro-
ductive hormones were normal in women with depres-
sion compared to control women in both the phases of
menstrual cycle.
In this study was found significantly lower circulating cor-
tisol levels in patients with CFS in contrast to high BDI
scores. However, there was no significant differentiation
in cortisol levels between the patients with low and high
depression scores. This is in contradiction to those hyper-
cortisolism of classical major depression and stress condi-
tion. More recent studies support this contradicton
[21,33]. In recent years, however, it has become increas-
ingly apparent that deppression is a heterogenous condi-
tion from both a psychological and a physiological
perspective [34]. Moreover, decreased HPA axis activity
was reported in some stress related states such as CFS,
atypical and seasonal depression [35]. These results sug-
gest that depression condition which is seen in CFS may
be different from classical depression. There may be over-
lapping between symptoms of CFS and those depressive
subtypes or reactive form of depression in CFS. This con-
dition may explaine both hypocortisolism in patients
with CFS and the lack of HPG axis hormone abnormali-
ties in this study.
Determining single basal levels of HPA and HPG axes do
not reflect activity of these axes entirely. Dynamic test
indicates differences in function of these axes. We did not
carry out dynamic characteristics of these axes. This point
is limit of our study.
In conclusion, we detected low cortisol levels in patients
with CFS in spite of their high depressive mood rate. How-
ever, in this study, we were unable to describe HPG axis
hormone abnormalities in both menstrual phases.
Hypocortisolism may be a biological factor that contrib-
utes fatigue chronicity and the reason of normality in
HPG axis. Depressive mood of chronic fatigue syndrome
may be different from classical depression. There are need
to carry out future controlled and larger clinical trials to
clarify these matters.
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